Characterization of a novel Graves� disease treatment that uses chimeric autoantigen receptor technology Skip to main content
Technologies

Characterization of a novel Graves� disease treatment that uses chimeric autoantigen receptor technology

ID: 2023-020 Characterization of a novel Graves� disease treatment that uses chimeric autoantigen receptor technology

Reach out to us directly to learn more about this technology - Phone: (801) 422-6266